BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 15613948)

  • 1. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.
    Schisterman EF; Perkins NJ; Liu A; Bondell H
    Epidemiology; 2005 Jan; 16(1):73-81. PubMed ID: 15613948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Youden Index and the optimal cut-point corrected for measurement error.
    Perkins NJ; Schisterman EF
    Biom J; 2005 Aug; 47(4):428-41. PubMed ID: 16161802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection.
    Ruopp MD; Perkins NJ; Whitcomb BW; Schisterman EF
    Biom J; 2008 Jun; 50(3):419-30. PubMed ID: 18435502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exact confidence interval estimation for the Youden index and its corresponding optimal cut-point.
    Lai CY; Tian L; Schisterman EF
    Comput Stat Data Anal; 2012 May; 56(5):1103-1114. PubMed ID: 27099407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved nonparametric estimation of the optimal diagnostic cut-off point associated with the Youden index under different sampling schemes.
    Yin J; Samawi H; Linder D
    Biom J; 2016 Jul; 58(4):915-34. PubMed ID: 26756282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point.
    Bantis LE; Nakas CT; Reiser B
    Biometrics; 2014 Mar; 70(1):212-23. PubMed ID: 24261514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROC curve analysis for biomarkers based on pooled assessments.
    Faraggi D; Reiser B; Schisterman EF
    Stat Med; 2003 Aug; 22(15):2515-27. PubMed ID: 12872306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal cut-point definition in biomarkers: the case of censored failure time outcome.
    Rota M; Antolini L; Valsecchi MG
    BMC Med Res Methodol; 2015 Mar; 15():24. PubMed ID: 25887743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the Youden Index and its associated cutoff point.
    Fluss R; Faraggi D; Reiser B
    Biom J; 2005 Aug; 47(4):458-72. PubMed ID: 16161804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of determining optimal cut-point of diagnostic biomarkers with application of clinical data in ROC analysis: an update review.
    Hassanzad M; Hajian-Tilaki K
    BMC Med Res Methodol; 2024 Apr; 24(1):84. PubMed ID: 38589814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme.
    Itoh M; Takahashi K; Nishida H; Sakagami K; Okubo T
    J Med Screen; 1996; 3(2):66-71. PubMed ID: 8849762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notes on the overlap measure as an alternative to the Youden index: How are they related?
    Samawi HM; Yin J; Rochani H; Panchal V
    Stat Med; 2017 Nov; 36(26):4230-4240. PubMed ID: 28809042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of confidence intervals for the maximum of the Youden index and the corresponding cutoff point of a continuous biomarker.
    Bantis LE; Nakas CT; Reiser B
    Biom J; 2019 Jan; 61(1):138-156. PubMed ID: 30408224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
    Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
    J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confidence intervals for the Youden index and its optimal cut-off point in the presence of covariates.
    Hu X; Li C; Chen J; Qin G
    J Biopharm Stat; 2021 May; 31(3):251-272. PubMed ID: 33074064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pooling biospecimens and limits of detection: effects on ROC curve analysis.
    Mumford SL; Schisterman EF; Vexler A; Liu A
    Biostatistics; 2006 Oct; 7(4):585-98. PubMed ID: 16531470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint confidence region estimation for area under ROC curve and Youden index.
    Yin J; Tian L
    Stat Med; 2014 Mar; 33(6):985-1000. PubMed ID: 24123069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of joint confidence regions for the optimal true class fractions of Receiver Operating Characteristic (ROC) surfaces and manifolds.
    Bantis LE; Nakas CT; Reiser B; Myall D; Dalrymple-Alford JC
    Stat Methods Med Res; 2017 Jun; 26(3):1429-1442. PubMed ID: 25911331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding diagnostic tests 3: Receiver operating characteristic curves.
    Akobeng AK
    Acta Paediatr; 2007 May; 96(5):644-7. PubMed ID: 17376185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer.
    Nakama H; Zhang B; Zhang X
    Eur J Cancer; 2001 Feb; 37(3):398-401. PubMed ID: 11239763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.